EFFECTS OF DENOSUMAB, A SUBCUTANEOUS RANKL INHIBITOR, ON THE PROGRESSION OF STRUCTURAL DAMAGE IN JAPANESE PATIENTS WITH RHEUMATOID ARTHRITIS TREATED WITH CSDMARDS: RESULTS FROM THE 12-MONTH DOUBLE BLIND PHASE 3, DESIRABLE STUDY
Author(s):
Takeuchi, T.; Tanaka, Y.; Soen, S.; Yamanaka, H.; Yoneda, T.; Tanaka, S.; Nitta, T.; Okubo, N.; Genant, H.K.; Heijde, D. van der
Published
2017
Publication type
Article / Letter to editor
Date issued
2017-06-30
Language
English
Is part of
Annals of the Rheumatic Diseases (2017), Vol. 76, p. 841-842
